Yupelri
Active Ingredient(s): RevefenacinFDA Approved: * November 9, 2018
Pharm Company: * THERAVANCE BIOPHARMA
Category: Lungs (Pulmonary)
Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The m... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.